Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Mucosal tolerance has been considered a potentially important pathway for the treatment of autoimmune disease, including human multiple sclerosis and experimental conditions such as experimental autoimmune encephalomyelitis (EAE). There is limited information on the capacity of commensal gut bacteria to induce and maintain peripheral immune tolerance. Inbred SJL and C57BL/6 mice were treated orally with a broad spectrum of antibiotics to reduce gut microflora. Reduction of gut commensal bacteria impaired the development of EAE. Intraperitoneal antibiotic-treated mice showed no significant decline in the gut microflora and developed EAE similar to untreated mice, suggesting that reduction in disease activity was related to alterations in the gut bacterial population. Protection was associated with a reduction of proinflammatory cytokines and increases in IL-10 and IL-13. Adoptive transfer of low numbers of IL-10-producing CD25+CD4+ T cells (>75% FoxP3+) purified from cervical lymph nodes of commensal bacteria reduced mice and in vivo neutralization of CD25+ cells suggested the role of regulatory T cells maintaining peripheral immune homeostasis. Our data demonstrate that antibiotic modification of gut commensal bacteria can modulate peripheral immune tolerance that can protect against EAE. This approach may offer a new therapeutic paradigm in the treatment of multiple sclerosis and perhaps other autoimmune conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“depletion of gut commensal bacteria by antibiotic treatment dampens the progression of experimental autoimmune encephalomyelitis in mice, which is suggested to be mediated by induction of IL-10-producing regulatory T cells.245”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [245]
In the citing paper
“Kasper L.’s group showed that oral but not systemic treatment with a classical pool of broad-spectrum antibiotics (ampicillin, vancomycin, neomycin, and metronidazole) ameliorated the development of acute EAE, in two mouse models (on C57BL/6 and SJL backgrounds) (18).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [18]
In the citing paper
“This effect suggested that the intestinal microbiota was responsible for the disease severity and the modulation of the adaptive immune response during disease development (18).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [18]
In the citing paper
“The better disease outcome upon oral antibiotic treatment was associated with a reduction of pro-inflammatory cytokines and an increase in regulatory cytokines like IL-10 (18).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 3×
“To test whether gut commensal bacteria are involved in the control of inflammatory demyelinating disease, we utilized a broad spectrum of antibiotics (ampicillin, vancomycin, neomycin sulfate, and metronidazole) to reduce the gut commensal bacteria in EAEsusceptible SJL mice (15).”
BackgroundInfluentialEcological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358
Coombes, J. L., Siddiqui, K. R. R., Arancibia-Cárcamo, C. V., Hall, J., Sun, C.-M., Belkaid, Y., & Powrie, F. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070590 · Cited by 2,710
Commensal Host-Bacterial Relationships in the Gut
Hooper, L. V., & Gordon, J. I. (2001) · Science · doi:10.1126/science.1058709 · Cited by 2,362
Sun, C.-M., Hall, J. A., Blank, R. B., Bouladoux, N., Oukka, M., Mora, J. R., & Belkaid, Y. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070602 · Cited by 1,881
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865 · cited 1×
“The role of IL-17 in the development of EAE has been of interest (34, 35).”
BackgroundIvanov, I. I., Frutos, R. D. L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B., Finlay, B. B., & Littman, D. R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.009 · Cited by 1,770
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Shevach, E. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.010 · Cited by 1,754
Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut
Artis, D. (2008) · Nature reviews. Immunology · doi:10.1038/nri2316 · Cited by 1,136 · cited 1×
“Pathogens share the same mucosa and it is the role of the immune system to control concurrently the responses to commensal and pathogenic organisms (3).”
BackgroundBenson, M. J., Pino-Lagos, K., Rosemblatt, M., & Noelle, R. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070719 · Cited by 847
Research works printed but not linked: 1
- 1999, Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response., 6249
Cited by
Items 401–500 of 635
Metabolomics in Otorhinolaryngology
Noto, A., Piras, C., Atzori, L., Mussap, M., Albera, A., Albera, R., Casani, A. P., Capobianco, S., & Fanos, V. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.934311 · Cited by 14
Microbiota Mediate Enhanced Exercise Capacity Induced by Exercise Training
Dowden, R. A., Wisniewski, P. J., Longoria, C. R., Oydanich, M. K., McNulty, T., RODRIGUEZ, E., Zhang, J., CAVALLO, M., Guers, J. J., Vatner, D. E., et al. (2023) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003170 · Cited by 14
Urinary Urea, Uric Acid and Hippuric Acid as Potential Biomarkers in Multiple Sclerosis Patients
Atya, H. B., Ali, S. A. E.-M., Hegazy, M. I., & Sharkawi, F. Z. E. (2017) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-017-0661-6 · Cited by 14
Gut Feelings: The Microbiome and Our Health
Fasano, A., & Flaherty, S. (2021) · The MIT Press eBooks · doi:10.7551/mitpress/11291.001.0001 · Cited by 14
IL7Rα Expression and Upregulation by IFNβ in Dendritic Cell Subsets Is Haplotype-Dependent
McKay, F. C., Hoe, E., Parnell, G. P., Gatt, P. N., Schibeci, S. D., Stewart, G. J., & Booth, D. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077508 · Cited by 14
Jaggers, R. M., DiSabato, D. J., Loman, B. R., Kontic, D., Spencer, K. D., Allen, J. M., Godbout, J. P., Quan, N., Gur, T. L., & Bailey, M. T. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s332793 · Cited by 13
Fischer, H. J., Witte, A., Walter, L., Gröne, H., van den Brandt, J., & Reichardt, H. M. (2016) · The FASEB Journal · doi:10.1096/fj.15-277384 · Cited by 13
Uhde, A., Herder, V., Khan, M. A., Ciurkiewicz, M., Schaudien, D., Teich, R., Floess, S., Baumgärtner, W., Huehn, J., & Beineke, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161883 · Cited by 13
Impact of Disease-Modifying Therapies on Gut–Brain Axis in Multiple Sclerosis
Negro, I. D., Pez, S., Versace, S., Marziali, A., Gigli, G. L., Tereshko, Y., & Valente, M. (2023) · Medicina · doi:10.3390/medicina60010006 · Cited by 12
Gut-derived metabolites drive Th17 cell pathogenicity in multiple sclerosis
Rebeaud, J., Vigne, S., Bressoud, V., Carre, R., Ruiz, F., Peter, B., Phillips, N. E., Siewert, L. K., Roloff, T. C., Egli, A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116326 · Cited by 12
Faecal microbiota transplantation—A clinical view
Mattner, J., Schmidt, F., & Siegmund, B. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.02.003 · Cited by 12
Obesity, gut microbiota, and multiple sclerosis: Unraveling the connection
Samara, A., Cantoni, C., Piccio, L. M., Cross, A. H., & Chahin, S. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104768 · Cited by 12
Overview of the Gut Microbiome
Blackmer‐Raynolds, L., & Sampson, T. R. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771463 · Cited by 12
Pérez-Muñoz, M. E., Sugden, S., Harmsen, H. J. M., Hart, B. A. ‘., Laman, J. D., & Walter, J. (2021) · iScience · doi:10.1016/j.isci.2021.102709 · Cited by 12
Arndt, A., Hoffacker, P., Zellmer, K., Goecer, O., Recks, M. S., & Küerten, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099794 · Cited by 12
Abdurasulova, I. N., Тарасова, Е. А., Ермоленко, Е. И., Eliseev, A. V., Matsulevich, A. V., Бисага, Г. Н., Skulyabin, D. I., Suvorov, A. N., & Клименко, В. М. (2015) · Medical academic journal · doi:10.17816/maj15355-67 · Cited by 12
Jia, R. F., Xiao, C., Zhang, Y., Hu, L.-Y., Jun-jun, Y., Zuo, R., Hu, Y., Xie, Y.-H., Ma, X., Li, Q., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101311 · Cited by 11
A One-Two Punch in the Gut May Trigger Multiple Sclerosis
Maghzi, A., & Weiner, H. L. (2020) · Immunity · doi:10.1016/j.immuni.2020.09.016 · Cited by 11
Microbiome Methods in Experimental Autoimmune Encephalomyelitis
Daberkow, D. P., Hoffman, K. R., Kohl, H. M., Long, T., Kirby, T. O., & Ochoa‐Repáraz, J. (2021) · Current Protocols · doi:10.1002/cpz1.314 · Cited by 11
Self-citationEscribano, B. M., Muñoz-Jurado, A., Luque, E., Conde, C., Feijóo, M., LaTorre, M., Valdelvira, M. E., Buendía, P., Giraldo, A. I., Caballero‐Villarraso, J., et al. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666211207101113 · Cited by 11
Ray, P., Chakraborty, S., Ghosh, A., & Aich, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.08.430372 · Cited by 11
Panyod, S., Wu, W., Lee, Y.-P., Lin, T., Kuo, P.-C., Yen, C.-S., Chen, Y., Chuang, H.-L., Lo, I., Yang, Y.-T., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.015 · Cited by 10
Kawakami, N., & Wekerle, H. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00442 · Cited by 10
Babu, A. K. S., Petersen, C., Paz, H. A., Iglesias‐Carres, L., Li, Y., Zhong, Y., Neilson, A. P., Wankhade, U. D., & Babu, P. V. A. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300386 · Cited by 10
Troutman, J. M., Sharma, S., Erickson, K. M., & Martinez, C. D. (2014) · Carbohydrate Research · doi:10.1016/j.carres.2014.06.003 · Cited by 10
Abdurasulova, I. N., Ермоленко, Е. И., Matsulevich, A. V., Abdurasulova, K. O., Тарасова, Е. А., Kudryavtsev, I. V., Бисага, Г. Н., Suvorov, A. N., & Клименко, В. М. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0484-1 · Cited by 10
Probiotic Applications in Autoimmune Diseases
de Oliveira, G. L. V. (2018) · InTech eBooks · doi:10.5772/intechopen.73064 · Cited by 10
Candon, S., Pérez, A., Marquet, C., Valette, F., Foray, A., Pelletier, B., Milani, C., Ventura, M., Bach, J., & Chatenoud, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147888 · Cited by 10
Cen, Q., Cui, Y., Jin, J., Feng, J., Xin, Y., Zhang, Z., Li, J., Wang, J., & Zhang, A. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2576657 · Cited by 9
Strzępa, A., Marcińska, K., Majewska‐Szczepanik, M., & Szczepanik, M. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105966 · Cited by 9
Microbiota-Immune System Interactions in Human Neurological Disorders
Huang, Q., Fang, Y., Liao, D., & Xia, J. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200726222138 · Cited by 9
Sepsis and multiple sclerosis: Causative links and outcomes
Miljković, D. M., Stanisavljević, S., Jensen, I. J., Griffith, T. S., & Badovinac, V. P. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.07.008 · Cited by 9
Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation
Jank, L., & Bhargava, P. (2023) · Neurologic Clinics · doi:10.1016/j.ncl.2023.07.005 · Cited by 9
Mracsko, E. Z., Stegemann‐Koniszewski, S., Na, S., Dalpke, A. H., Bruder, D., Lasitschka, F., & Veltkamp, R. C. (2017) · Cerebrovascular Diseases · doi:10.1159/000452136 · Cited by 9
The NIH Human Microbiome Project
Proctor, L. M., Chhibba, S., McEwen, J. E., Peterson, J. L., Wellington, C., Baker, C., Giovanni, M. Y., McInnes, P., & Lunsford, R. D. (2013) · Wiley eBooks · doi:10.1002/9781118409855.ch1 · Cited by 9
Gut microbiota linked to autoimmune uveitis
Horai, R. (2018) · Annals of Eye Science · doi:10.21037/aes.2017.03.02 · Cited by 9
The Role of Gut-derived Short-Chain Fatty Acids in Multiple Sclerosis
Saadh, M. J., Ahmed, H. M., Alani, Z. K., Zuhairi, R. A. H. A., Almarhoon, Z. M., Ahmad, H., Ubaid, M., & Alwan, N. H. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08783-4 · Cited by 8
Kowalczyk, P. K., Strzępa, A., & Szczepanik, M. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00217-3 · Cited by 9
Overview of microbial therapeutics in immunological disorders
Mishra, R., Mohanty, S., Mahapatra, S., & Prasad, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00008-2 · Cited by 8
Multiple sclerosis and the intestine: Chasing the microbial offender
Peters, A., Gerdes, L. A., & Wekerle, H. (2024) · Immunological Reviews · doi:10.1111/imr.13357 · Cited by 8
Mihailovich, M., Bajić, S. S., Dinić, M., Đokić, J., Živković, M., Radojević, D., & Golić, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810156 · Cited by 8
Taylor, J., Clarke, E., Baker, K. C., Lauder, A. P., Kim, D. J., Bailey, A., Wu, G. D., Collman, R. G., Doyle‐Meyers, L. A., Russell‐Lodrigue, K., et al. (2018) · PeerJ · doi:10.7717/peerj.4612 · Cited by 8
Harguindey, S., Alfarouk, K. O., Orozco, J. D. P., Reshkin, S. J., & Devesa, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052454 · Cited by 8
das Neves, S. P., Serre-Miranda, C., Sousa, J. C., Costa, P., Sousa, N., Cerqueira, J., & Marques, F. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577872 · Cited by 8
Immunoregulation of multiple sclerosis by gut environmental factors
Croxford, J. L., & Miyake, S. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12252 · Cited by 8
Wang, C., Li, H., Wang, T., Li, X., 刘建伟, Deng, A., & Jiao, X. (2025) · International Ophthalmology · doi:10.1007/s10792-025-03921-8 · Cited by 7
Gut Microbiome as Potential Therapeutics in Multiple Sclerosis
Zhu, W., Dykstra, K., Zhang, L., & Xia, Z. (2021) · Current Treatment Options in Neurology · doi:10.1007/s11940-021-00693-1 · Cited by 7
Mukhopadhyay, S., Ray, P., & Aich, P. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121212 · Cited by 7
Koya, V., Campbell, A. M., McLaughlin, P. J., Tewari, D., Wilson, R. P., & Cooper, T. K. (2012) · Veterinary Pathology · doi:10.1177/0300985811429809 · Cited by 7
El holobionte enfermo, el ejemplo de la esclerosis múltiple
Castillo-Álvarez, F., & Marzo-Sola, M. E. (2018) · Medicina Clínica · doi:10.1016/j.medcli.2018.08.019 · Cited by 7
Peretti, S., Torracchi, S., Russo, E., Bonomi, F., Fiorentini, E., Aoufy, K. E., Bruni, C., Lepri, G., Orlandi, M., Chimenti, M. S., et al. (2022) · Genes · doi:10.3390/genes14010089 · Cited by 7
The influence of aging and the microbiome in multiple sclerosis and other neurologic diseases
Fettig, N. M., Pu, A., Osborne, L. C., & Gommerman, J. L. (2024) · Immunological Reviews · doi:10.1111/imr.13361 · Cited by 7
Libbey, J. E., Sanchez, J. M. S., Fleming, B. A., Doty, D. J., DePaula-Silva, A. B., Mulvey, M. A., & Fujinami, R. S. (2020) · Beneficial Microbes · doi:10.3920/bm2020.0012 · Cited by 7
Suzuki, S., Miyamoto, K., Tojo, A. O., Yoshimatsu, Y., Teratani, T., Uchida, H., Nemoto, Y., Okamoto, R., Sihombing, A. M., Sato, T., et al. (2026) · Science Immunology · doi:10.1126/sciimmunol.aec1627 · Cited by 6
Ladakis, D. C., & Bhargava, P. (2023) · CNS Drugs · doi:10.1007/s40263-023-00986-w · Cited by 6
The Role of the Intestinal Microbiome in Multiple Sclerosis—Lessons to Be Learned from Hippocrates
El-Sayed, M. M., Mohak, S., Gala, D., Fabian, R., Péterfi, Z., & Fábián, Z. (2023) · Biology · doi:10.3390/biology12121463 · Cited by 6
The Intestinal Microbiota and Therapeutic Responses to Immunotherapy
Herrera, P. S., & van den Brink, M. R. M. (2024) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062722-035210 · Cited by 6
Yoon, S., Park, S., Jung, S. E., Lee, C., Kim, W.-K., Choi, I.-D., & Ko, G. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2401.01012 · Cited by 6
Murayama, R., Liu, G., Zhao, M., Xu, D., Zhu, T., Cai, Y., Yue, Y., Nakamura, H., & Hashimoto, K. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173946 · Cited by 6
Complement C6 deficiency exacerbates pathophysiology after spinal cord injury
Su, D., Hooshmand, M. J., Galvan, M. D., Nishi, R. A., Cummings, B. J., & Anderson, A. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-76441-3 · Cited by 6
Metabolomics and Microbiomics: New Potential Strategies in Chronic Pain Syndrome
Piras, C., Pintus, B. M., Noto, A., Evangelista, M., Fanos, V., Musu, M., Mussap, M., Atzori, L., Sardo, S., & Finco, G. (2022) · Journal of Pain Research · doi:10.2147/jpr.s354516 · Cited by 6
Relationship between medical history and multiple sclerosis: A-case-control study
Esfandiari, F., Ghazaiean, M., Darvishi‐Khezri, H., & Baghbanian, S. M. (2023) · Medicine · doi:10.1097/md.0000000000033906 · Cited by 6
Gut Microbes: The Gut Brain Connection
Lynch, C. M. K., O’Riordan, K. J., Clarke, G. A., & Cryan, J. F. (2023) · Springer eBooks · doi:10.1007/978-3-031-46712-7_4 · Cited by 6
Smolianov, V., Dehmel, T., Vollmar, P., Mausberg, A. K., Kieseier, B. C., Hemmer, B., Hartung, H. P., & Hofstetter, H. H. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-59 · Cited by 6
Effect of Natural Milk Antibodies on Intestinal Flora
Iwatsuki, S., Kijima, Y., & Shionoya, H. (2011) · NIPPON SHOKUHIN KOGYO GAKKAISHI · doi:10.3136/nskkk.58.236 · Cited by 6
D’Onofrio, A. M., Gomez-Nguyen, A., Camardese, G., Scaldaferri, F., Burberry, A., & Cominelli, F. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03847-4 · Cited by 5
Controllers of cutaneous regulatory T cells: ultraviolet radiation and the skin microbiome
Schwarz, T., & Schwarz, A. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0252 · Cited by 5
La asociación entre microbioma intestinal y uveítis autoinmune
Kalogeropoulos, D., Barry, R. J., & Kalogeropoulos, C. D. (2022) · Archivos de la Sociedad Española de Oftalmología · doi:10.1016/j.oftal.2021.01.019 · Cited by 5
Ferreira, C., Carvalho, F. S., Vieira, P., Alves, A. D. C., Palavra, F., Almeida, J., Alves, V., Coscueta, E. R., Dias‐Pereira, P., Pintado, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1682183 · Cited by 5
Cellular Immunity and Multiple Sclerosis: Current Understanding
Sato, W., & Yamamura, T. (2016) · Springer eBooks · doi:10.1007/978-4-431-55594-0_1 · Cited by 5
Abdurasulova, I. N. (2022) · Medical academic journal · doi:10.17816/maj108241 · Cited by 5
Raghib, M. F., & Bernitsas, E. (2023) · Biomedicines · doi:10.3390/biomedicines11113069 · Cited by 5
From Microbes to Immunity: A Comprehensive Review of Microbiome Modulation
Shahid, A., Fatima, M., Khan, M. S. I., Ali, U., Fareed, S. Z., & Qureshi, M. A. (2023) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v3i2.238 · Cited by 5
Gut microbiota and brain development: A review
Varier, K. M., Karandikar, A., Liu, W., Chen, J., Ben‐David, Y., Shen, X., Chinnasamy, A., & Gajendran, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821265-3.00018-9 · Cited by 5
Joscelyn, J., Ochoa‐Repáraz, J., & Kasper, L. H. (2019) · Current clinical neurology · doi:10.1007/978-3-030-24436-1_2 · Cited by 5
Self-citationAhmad, I., Omura, S., Khadka, S., Sato, F., Park, A.-M., Rimal, S., & Tsunoda, I. (2025) · Cells · doi:10.3390/cells14120871 · Cited by 4
Gut microbiota modulates CNS barrier function in murine model for multiple sclerosis
Xie, J., Burgelman, M., Dujardin, P., Castelein, J., Imschoot, G. V., Wonterghem, E. V., Lernout, H., Schetters, S. T. T., Vandendriessche, C., Hoecke, L. V., et al. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00724-y · Cited by 4
Mikrobiota und Multiple Sklerose
Gerdes, L. A., Yoon, H., & Peters, A. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-01012-w · Cited by 4
The interactions between gut and brain in psychiatric and neurological disorders
Shin, C., & Kim, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821927-0.00010-3 · Cited by 4
Abdurasulova, I. N., Тарасова, Е. А., Matsulevich, A. V., Eliseev, A. V., Ермоленко, Е. И., Suvorov, A. N., & Клименко, В. М. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0401-7 · Cited by 4
Tungland, B. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814649-1.00005-3 · Cited by 4
Disease of the holobiont, the example of multiple sclerosis
Castillo-Álvarez, F., & Marzo-Sola, M. E. (2019) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2018.08.012 · Cited by 4
Fatty Acids and Gut Microbiota
Costantini, L., Molinari, R., Farinon, B., & Merendino, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00026-7 · Cited by 4
The association between intestinal microbiome and autoimmune uveitis
Kalogeropoulos, D., Barry, R. J., & Kalogeropoulos, C. D. (2022) · Archivos de la Sociedad Española de Oftalmología (English Edition) · doi:10.1016/j.oftale.2021.01.012 · Cited by 4
Multiple Sklerose: Was können wir an ihr verstehen und wie behandeln wir sie?
Sommer, M. (2016) · Der Merkurstab · doi:10.14271/dms-20667-de · Cited by 4
Sivamani, Y., Sajal, H., & Elayaperumal, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95715-1.00011-x · Cited by 3
The Influence of Gut Microbiota in Psychosis
Murray, N., Ghomi, R. H., Nemani, K., & O’Connor, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99971-7.00018-7 · Cited by 3
Microorganisms in Pathogenesis and Management of Acute Disseminated Encephalomyelitis (ADEM)
Agrawal, A., & Bhattacharyya, S. (2022) · Springer eBooks · doi:10.1007/978-981-19-4800-8_11 · Cited by 3
Sand, I. K., & Baranzini, S. E. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518761167 · Cited by 3
Clientelismo y candidaturas corporativas bajo el sufragio censitario
Bellver, F. J. V. (1994) · Boletín de la Institución Libre de Enseñanza · Cited by 3
Childbirth delivery mode and the risk of multiple sclerosis: a prospective population-based study
Kapali, A., Daltveit, A. K., Myhr, K., Bjørnevik, K., Baldin, E., Pugliatti, M., Riise, T., & Cortese, M. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-331241 · Cited by 3
Mucosal Immunity and the Intestinal Microbiome in the Development of Critical Illness
Madách, K., Kristóf, K., Tulassay, E., Iványi, Z. D., Erdei, A., Király, A., Gál, J., & Bajtay, Z. (2011) · ISRN Immunology · doi:10.5402/2011/545729 · Cited by 3
Darmflora als Regulator des Immunsystems
Chang, H., & Kamradt, T. (2011) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-011-0907-2 · Cited by 3
The Influence of Diet and the Gut Microbiota in Schizophrenia
Ghomi, R. H., & Nemani, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802304-4.00016-5 · Cited by 3
Elfeky, M., Kamimura, D., Arima, Y., Murakami, M., & Steinman, L. (2017) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12399 · Cited by 3
Mining for disease-associated microbial metabolites in an age-dependent model of multiple sclerosisPreprint
Pu, A., Fettig, N. M., Polyzois, A., Chao, G. Y. C., Naouar, I., Hohman, L. S., Fontaine, M. A., Zuo, M., Champagne-Jorgensen, K., Copeland, J. K., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.27.595846 · Cited by 3
Zhang, S., Chen, W., Ma, C., Luo, Y., Dong, L., Hu, X., Chen, F., & Li, D. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250215 · Cited by 2
The Microbiota and Its Modulation in Immune-Mediated Disorders
Pevsner‐Fischer, M., Rot, C., Tuganbaev, T., & Elinav, E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803302-9.00010-5 · Cited by 2
Environmental Factors and Their Regulation of Immunity in Multiple Sclerosis
Trojano, M., & Avolio, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801914-6.00008-8 · Cited by 2
Metadata
- Authors
- Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Foureau, D. M., Haque-Begum, S., & Kasper, L. H.
- Affiliations
- Department of Medicine
- Dartmouth College (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11
- Volume
- 183
- Issue
- 10
- Pages
- 6041-6050
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2112999168
- Cited by
- 590
- References
- 35
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 31 · 2023: 39 · 2022: 46 · 2021: 63 · 2020: 55 · 2019: 37 · 2018: 60 · 2017: 49 · 2016: 35 · 2015: 30 · 2014: 35 · 2013: 20 · 2012: 17
- FWCI
- 13.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Multiple Sclerosis Society (CA1027A1/3)
- Teva Pharmaceutical Industries
- Dartmouth College
- Multiple Sclerosis Society
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- gut commensal bacteria, experimental autoimmune encephalomyelitis, mucosal tolerance, peripheral tolerance, antibiotic-induced dysbiosis, multiple sclerosis, regulatory T cells, Foxp3, IL-10, IL-13, inflammatory cytokines, CD4+CD25+ T cells, adoptive transfer, autoimmune disease therapy
- MeSH terms
- Administration, Oral, Animals, Anti-Bacterial Agents, Bacteria, Encephalomyelitis, Autoimmune, Experimental, Female, Glycoproteins, Intestines, Mice, Inbred C57BL, Peptide Fragments, Cytokines, Interleukin-10, Interleukin-13, Immunity, Mucosal, Myelin Proteolipid Protein, Adoptive Transfer, T-Lymphocytes, Regulatory, Mice, Myelin-Oligodendrocyte Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.